Álvarez HL, Yánez GJA, Velásquez CJ

Language: Spanish
References: 14
Page: 101-109
PDF size: 99.81 Kb.

ABSTRACT

Objective. To evaluate correlation between clinical evolution and cerebrospinal fluid findings with procoagulant activity in children with bacterial meningitis.
Materials and methods. We studied 13 patients with bacterial meningitis, from 1 month to 10 years old. Samples of cerebrospinal fluid were took before and after treatment. In all samples we determined procoagulant activity.
Results. We compared clinical signs and cerebrospinal fluid characteristics with procoagulant activity before and after treatment and we found no correlation with changes in clinical signs and cerebrospinal fluid characteristics.
Conclusions. In children with bacterial meningitis, procoagulant activity is useful as a diagnosis test but not as a clinical evolution marker.

REFERENCES

1. Bell WE. Meningitis bacteriana: conceptos generales y tratamiento, en Bell WE, McCormick WF. Infecciones neurológicas en el niño, Barcelona, Salvat Editores, 1979: 5-26.

2. Feigin RD, Boradman DR, Bush JK. Acute bacterial meningitis, en Dickerman JD, Lucey JF. The critically ill child, diagnosis and medical management. Phyladelphia WB Saunders, 1985, 3th edition: 18-44.

3. Preston EF, Malia GR, Sworn JM, Timperley RW, Blackburn KE. Disseminated intravascular coagulatio as a consequence of cerebral damage. J Neurol Neurosurg and Psychiat 1974; 37: 241-248.

4. Keimowitz MR, Annis LB. Disseminated intravascular coagulation associated with massive brain injury. J Neurosurg 1973; 39: 178-180.

5. Enseleit WH, Domer FR, Jarrot DM, Baricos MH. Cerebral phospholipid content and Na+, -k+, -APTase activity during ischemia and postischemia, repercusion in the mongolian gerbil. J Neurochemist 1984; 43: 320-326.

6. Niewiarowsky S, Hausmanova I, Wegryznowics Z. Blood clotting factors in cerebrospinal fluid. J Clin Path 1962; 15: 497-500.

7. Brueton MJ, TugwellP, Whittle C, Greenwood BM. Fibrin degradation products in the serum and cerebrospinal fluid of patient with group A meningococccal meningitis. J Clin Path 1974; 27: 402-404.

8. Graeber EJ, Stuart MJ. Spinal- fluid procoagulant activity: A sensitive indicator of central nervous damage. Lancet 1978; 5: 285-288.

9. Nagda KK. Procoagulant activity of cerebrospinal fluid inhealth and disease. Indian J Med Res 1981; 74: 107-110.

10. Nagda KK. Isolation and purification of a procoagulant from human cerebrospinal fluid. Indian J Biochem Biophys 1982; 19, 4: 280-282.

11. Nagda KK. Mechanism of blood coagulation by pirified cerebrospinal procoagulan. Indian J Exp Biol 1983; 21, 9: 507-508.

12. Bennet JS. Coagulación sanguínea y pruebas de coagulación. Clin Med Norteam 1984; 553-569.

13. Méndez CG, Kumate J. Valoración de la actividad procoagulante de líquido cefalorraquídeo como prueba para diagnóstico diferencial entre diversos cuadros meningoencefalíticos. Tesis de posgrado. Curso de Pediatría Médica, Hospital Infantil de México, 1981.

14. Torres D, Velásquez CJ. Actividad procoagulante de líquido cefalorraquídeo como indicador de daño al Sistema Nervioso Central. Tesis de posgrado. Curso Universitario de Pediatría Médica. Hospital General, Centro Médico “La Raza”, Instituto Mexicano del Seguro Social, 1985.